Literature DB >> 30652607

The Benefits and Challenges of Using Patient Decision Aids to Support Shared Decision Making in Health Care.

Anshu Ankolekar1, Andre Dekker1, Rianne Fijten1, Adriana Berlanga1.   

Abstract

Shared decision making (SDM) and patient-centered care require patients to actively participate in the decision-making process. Yet with the increasing number and complexity of cancer treatment options, it can be a challenge for patients to evaluate clinical information and make risk-benefit trade-offs to choose the most appropriate treatment. Clinicians face time constraints and communication challenges, which can further hamper the SDM process. In this article, we review patient decision aids (PDAs) as a means of supporting SDM by presenting clinical information and risk data to patients in a format that is accessible and easy to understand. We outline the benefits and limitations of PDAs as well as the challenges in their development, such as a lengthy and complex development process and implementation obstacles. Lastly, we discuss future trends and how change on multiple levels-PDA developers, clinicians, hospital administrators, and health care insurers-can support the use of PDAs and consequently SDM. Through this multipronged approach, patients can be empowered to take an active role in their health and choose treatments that are in line with their values.

Entities:  

Mesh:

Year:  2018        PMID: 30652607     DOI: 10.1200/CCI.18.00013

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN: 2473-4276


  8 in total

1.  Feasibility of Measuring Preferences for Chemotherapy Among Early-Stage Breast Cancer Survivors Using a Direct Rank Ordering Multicriteria Decision Analysis Versus a Time Trade-Off.

Authors:  Laura Panattoni; Charles E Phelps; Tracy A Lieu; Stacey Alexeeff; Suzanne O'Neill; Jeanne S Mandelblatt; Scott D Ramsey
Journal:  Patient       Date:  2020-10       Impact factor: 3.883

2.  A Pilot Randomized Clinical Trial of a Goals-of-Care Decision Aid for Surrogates of Severe Acute Brain Injury Patients.

Authors:  Susanne Muehlschlegel; Kelsey Goostrey; Julie Flahive; Qiang Zhang; Jolanta J Pach; David Y Hwang
Journal:  Neurology       Date:  2022-07-19       Impact factor: 11.800

3.  Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy.

Authors:  Thomas Iseli; Thierry Berghmans; Markus Glatzer; Achim Rittmeyer; Gilbert Massard; Valérie Durieux; Thomas Buchsbaum; Paul Martin Putora
Journal:  ERJ Open Res       Date:  2020-09-14

4.  Implementing lung cancer screening in primary care: needs assessment and implementation strategy design.

Authors:  Thomas J Reese; Chelsey R Schlechter; Heidi Kramer; Polina Kukhareva; Charlene R Weir; Guilherme Del Fiol; Tanner Caverly; Rachel Hess; Michael C Flynn; Teresa Taft; Kensaku Kawamoto
Journal:  Transl Behav Med       Date:  2022-02-16       Impact factor: 3.626

5.  Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists.

Authors:  Markus Glatzer; Pawel Leskow; Francesca Caparrotti; Olgun Elicin; Markus Furrer; Franco Gambazzi; André Dutly; Hans Gelpke; Matthias Guckenberger; Jürg Heuberger; Rolf Inderbitzi; Stefano Cafarotti; Wolfram Karenovics; Peter Kestenholz; Gregor Jan Kocher; Peter Kraxner; Thorsten Krueger; Francesco Martucci; Christoph Oehler; Mahmut Ozsahin; Alexandros Papachristofilou; Dirk Wagnetz; Kathrin Zaugg; Daniel Zwahlen; Isabelle Opitz; Paul Martin Putora
Journal:  Transl Lung Cancer Res       Date:  2021-04

6.  PROSHADE Protocol: Designing and Evaluating a Decision Aid for Promoting Shared Decision Making in Opportunistic Screening for Prostate Cancer: A Mix-Method Study.

Authors:  Blanca Lumbreras; Lucy Anne Parker; Pablo Alonso-Coello; Javier Mira-Bernabeu; Luis Gómez-Pérez; Juan Pablo Caballero-Romeu; Salvador Pertusa-Martínez; Ana Cebrián-Cuenca; Irene Moral-Peláez; Maite López-Garrigós; Carlos Canelo-Aybar; Elena Ronda; Mercedes Guilabert; Antonio Prieto-González; Ildefonso Hernández-Aguado
Journal:  Int J Environ Res Public Health       Date:  2022-07-22       Impact factor: 4.614

7.  Do You Employ Shared Decision-Making in Your Practice?

Authors:  Beth Faiman
Journal:  J Adv Pract Oncol       Date:  2022-06-21

8.  International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?

Authors:  Paul Martin Putora; Pawel Leskow; Fiona McDonald; Tim Batchelor; Matthiew Evison
Journal:  ERJ Open Res       Date:  2020-02-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.